ARTICLE | Clinical News
Xcytrin motexafin gadolinium: Updated Phase III data
June 5, 2006 7:00 AM UTC
New data analyses done by adjusting for treatment arm imbalances from the international Phase III SMART trial in 554 patients showed that Xcytrin significantly prolonged time to neurologic progression...